Adcytherix is a clinical-stage biopharmaceutical company developing novel antibody-drug conjugates (ADCs) for cancer and other serious diseases with high unmet medical need. Its ambition is to become a leading next-generation ADC design company, combining clinically validated targets and innovative payloads derived from approved cancer drugs to deliver differentiated, de-risked therapies driven by patient need.

Founded by Jack Elands, CEO, Adcytherix is led by a seasoned team, guided by leading ADC experts, and backed by a top-tier international syndicate of life science investors.

Adcytherix is based in Marseille, France, with subsidiaries in the US and the Netherlands.

Adcytherix

Org chart

Teams

Offices